share_log
Benzinga ·  Apr 30 06:34
NanoViricides Reports That The Phase I NV-387 Clinical Trial Is Completed Successfully And Data Lock Is Expected Soon
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment